DEPTOR, an acronym for DEP domain-containing mTOR-interacting protein, is a pivotal regulator within the mammalian target of rapamycin (mTOR) signaling pathway, which governs fundamental cellular processes including cell growth, proliferation, metabolism, and survival. As a negative regulator of mTOR activity, DEPTOR modulates the function of both mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Through its interaction with mTOR complexes, DEPTOR exerts inhibitory effects on mTOR kinase activity, consequently suppressing downstream signaling events critical for protein synthesis and cell growth. By binding to mTOR complexes, DEPTOR hinders the phosphorylation of key substrates such as ribosomal protein S6 kinase (S6K) and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1), thus dampening the proliferative and anabolic responses mediated by mTOR signaling.
Activation of DEPTOR is intricately regulated by various cellular mechanisms that influence its stability, abundance, and interaction with mTOR complexes. Several signaling pathways and post-translational modifications are implicated in the activation of DEPTOR and subsequent modulation of mTOR signaling. For instance, phosphorylation events mediated by protein kinases can impact DEPTOR stability and function, either enhancing or attenuating its inhibitory effects on mTOR complexes. Additionally, stimuli such as growth factors or nutrient availability may regulate DEPTOR expression levels, thereby modulating its interaction with mTOR complexes and subsequent downstream signaling cascades. Overall, understanding the mechanisms underlying DEPTOR activation provides valuable insights into the intricate regulation of mTOR signaling and its impact on cellular homeostasis and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Amino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester | 305834-79-1 | sc-479756 | 25 mg | $380.00 | ||
Also called SC79, this compound is a direct activator of DEPTOR, functioning by activating Akt. It enhances Akt phosphorylation, leading to the downstream activation of DEPTOR and subsequent modulation of the PI3K-Akt-mTOR pathway. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin is a direct DEPTOR activator that functions by activating the PI3K-Akt pathway. It binds to the insulin receptor, initiating downstream signaling events that include DEPTOR activation, influencing cell growth and survival. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is a direct DEPTOR activator that functions by activating Akt. It enhances Akt phosphorylation, leading to the downstream activation of DEPTOR and subsequent modulation of the PI3K-Akt-mTOR pathway. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride is an indirect DEPTOR activator that activates the Wnt pathway. By inhibiting GSK-3β, it stabilizes β-catenin, leading to the modulation of the PI3K-Akt-mTOR pathway and subsequent activation of DEPTOR. | ||||||